Related Experiment Video
Updated: Feb 15, 2026

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells
Published on: February 2, 2024
Delta-like Ligand-4-Notch Signaling Inhibition Regulates Pancreatic Islet Function and Insulin Secretion
Fabienne Billiard1, Sevasti Karaliota2, Bei Wang1
1Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
Abstract:
Although Notch signaling has been proposed as a therapeutic target for type-2 diabetes, liver steatosis, and atherosclerosis, its direct effect on pancreatic islets remains unknown. Here, we demonstrated a function of Dll4-Notch signaling inhibition on the biology of insulin-producing cells. We confirmed enhanced expression of key Notch signaling genes in purified pancreatic islets from diabetic NOD mice and showed that treatment with anti-Dll4 antibody specifically abolished Notch signaling pathway activation. Furthermore, we showed that Notch inhibition could drive proliferation of β-islet cells and confer protection from the development of STZ-induced diabetes. Importantly, inhibition of the Dll4 pathway in WT mice increased insulin secretion by inducing the differentiation of pancreatic β-islet cell progenitors, as well as the proliferation of insulin-secreting cells. These findings reveal a direct effect of Dll4-blockade on pancreatic islets that, in conjunction with its immunomodulatory effects, could be used for unmet medical needs hallmarked by inefficient insulin action.
Insights
Inhibiting Dll4-Notch signaling promotes insulin-producing beta-islet cell proliferation and differentiation. This approach offers potential for treating diabetes by enhancing insulin secretion and protecting against diabetes development.
Area of Science:
- Endocrinology
- Immunology
- Cell Biology
Background:
- Notch signaling is implicated in various diseases, but its role in pancreatic islets is unclear.
- Understanding Notch signaling's impact on pancreatic islets is crucial for developing diabetes therapies.
Purpose of the Study:
- To investigate the direct effects of Dll4-Notch signaling inhibition on pancreatic islet biology.
- To explore the therapeutic potential of Dll4 blockade in diabetes.
Main Methods:
- Assessed Notch signaling gene expression in pancreatic islets from diabetic NOD mice.
- Treated mice with an anti-Dll4 antibody to inhibit Notch signaling.
- Evaluated the impact of Notch inhibition on beta-islet cell proliferation, differentiation, and insulin secretion.
- Studied STZ-induced diabetes models.
Main Results:
- Confirmed elevated Notch signaling gene expression in diabetic islets.
- Anti-Dll4 antibody treatment effectively abolished Notch pathway activation.
- Notch inhibition promoted beta-islet cell proliferation and protected against STZ-induced diabetes.
- Inhibition of Dll4 increased insulin secretion by enhancing beta-islet cell progenitor differentiation and insulin-secreting cell proliferation.
Conclusions:
- Dll4-Notch signaling directly influences pancreatic islet biology, promoting beta-islet cell expansion and function.
- Dll4 blockade presents a potential therapeutic strategy for diabetes, addressing inefficient insulin action.
More Related Videos
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Pancreatic Juice and Secretion
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
Regulation of Hormone Secretion
Humoral...
Insulin: The Receptor and Signaling Pathways
Ligand Binding and Linkage

